FDA approves Medtronic device for Parkinson's treatment
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain activity, potentially improving symptom control, according to a Feb. 24 news release from the company.
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
News Medical on MSN2h
Can coffee push back Parkinson’s? New study uncovers key genetic linkHigher coffee consumption is causally linked to delayed onset of Parkinson’s disease but does not affect disease risk or ...
4hon MSN
No Escape From Now' will peer behind the Black Sabbath star's public persona to reveal the devastating setbacks since a ...
Wrexham manager Phil Parkinson has paid tribute to Max Cleworth's finishing ability after the defender scored his seventh ...
Sleep problems in Parkinson disease are highly prevalent, with over 80% of patients reporting sleep disturbances and insomnia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback